In-vitro Fertilization Market Size, Share & Trends Report

In-vitro Fertilization Market Size, Share & Trends Analysis Report By Instrument (Disposable Devices, Culture Media), By Procedure Type (Fresh Donor, Frozen Donor), By End-use, By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Feb, 2021
  • Base Year for Estimate: 2020
  • Report ID: 978-1-68038-823-7
  • Format: Electronic (PDF)
  • Historical Data: 2016 - 2019
  • Number of Pages: 120

Report Overview

The global in-vitro fertilization market size was estimated at USD 14.2 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 6.5% from 2021 to 2028. Key factors that are driving the market include rising reprotourism and the increasing incidence rate of male and female infertility.

U.S. IVF market size, by instrument, 2016 - 2028 (USD Million)

Infertility is one of the major health concerns faced by individuals globally. According to the American Pregnancy Association, male infertility accounts for 30.0% of infertility cases and contributes to around one-fifth of infertility cases. Moreover, as the female literacy rate is increasing, they prefer to plan a family late due to career orientation, and that in turn makes women dependent on fertility treatments as fertility decreases with age.

Availability of funds is leading to an increase in the adoption of In Vitro Fertilization (IVF) procedures. In December 2016, the Ontario government announced a USD 50 million fertility program to cover IVF treatment for 5,000 people. Furthermore, the Singapore government offers around 75% co-funding for various ART procedures such as IVF, Gamete Intrafallopian Transfer (GIFT), and Intracytoplasmic Sperm Injection (ICSI). In January 2015, the Centers for Disease Control and Prevention (CDC) reported that the use of ICSI has increased from 36.4% in 1996 to around 76.2% in 2012.

To increase the success rate of IVF, techniques such as Testicular Sperm Extraction (PESA and TESE) are being introduced along with the development of new products. In June 2018, an Australian scientist developed an artificial intelligence tool called Ivy for the identification of an embryo with the best chance of pregnancy. Such technologies help to increase the success rate of IVF pregnancies.

The onset of the COVID-19 pandemic led to the suspension of fertility treatments that affected the women psychologically whose treatments were canceled. According to a study published by the American Society for Reproductive Medicine, in October 2020, around 62% of participants desired to begin treatment once the COVID-19 restrictions are eased. Treatment centers are now being permitted to resume treatments with a requirement to adhere to certain guidelines. The Human Fertilisation and Embryology Authority permitted to resume treatments in June 2020 and requires individuals infected with COVID-19 to wait for 28 days post-recovery prior to initiating treatment.

Instrument Insights

The culture media segment dominated the market for IVF and accounted for the largest revenue share of more than 40.0% in 2020 due to factors such as availability of funding and an increase in research activities to improve the culture media. However, as industry players are introducing disposable devices such as needles, slides, and chambers to meet the sterility and regulatory requirements, the disposable devices segment is expected to grow at the fastest rate in the coming years.

Procedure Insights

The fresh non-donor segment dominated the market for IVF and accounted for the largest revenue share of 45.0% in 2020. This growth is owing to the high success rate of the procedure in the first attempt. As the procedure can be performed even in complicated cases, the segment is likely to witness the fastest growth in the coming years. For instance, a patient suffering from Ovarian Hyperstimulation Syndrome (OHSS) can opt for this type of IVF procedure.

End-use Insights

The fertility clinics segment dominated the market for IVF and accounted for the largest revenue share of around 80.0% in 2020 and is likely to dominate throughout the forecast period. With a rise in demand for ART treatments, the number of fertility clinics and ART centers is increasing considerably. Factors such as cost-effectiveness, availability of specialists, and minimal or no chances of hospital-acquired infections are some of the key factors that can be attributed to the growth of fertility clinics.

Regional Insights

Europe dominated the in vitro fertilization market and accounted for the largest revenue share of 37.0% in 2020, due to factors such as medical tourism and legal revisions related to IVF techniques. An increasing number of people from the U.S. are traveling to the Czech Republic to avail IVF treatments at lower costs.

Global IVF market share, by region, 2020 (%)

As per an ESHRE fact sheet, in January 2017, some reimbursement is available for ART in almost all EU member states (except Lithuania and Ireland). The demand for IVF treatment is expected to increase in the Asia Pacific region due to initiatives to create awareness regarding IVF, change in the regulatory landscape, and fertility tourism.

Key Companies & Market Share Insights

Geographical expansion, mergers, and product innovation and commercialization are the key strategies of the market players operating in the market. In July 2019, Vitrolife and Prime Tech entered into a collaboration agreement to design and market the Piezo technique for better Intracytoplasmic Sperm Injection (ICSI) procedure in human IVF globally except for Thailand, Japan, and Malaysia. Some of the prominent players in the in-vitro fertilization market include:

  • OvaScience

  • EMD Serono Inc.

  • Vitrolife AB

  • Irvine Scientific

  • Cook Medical Inc

  • Cooper Surgical Inc.

  • Genea Biomedx

  • Thermo Fisher Scientific Inc.

  • Progyny, Inc.

  • Boston IVF

In-vitro Fertilization Market Report Scope 

Report Attribute

Details

Market size value in 2021

USD 21.9 billion

Revenue forecast in 2028

USD 33.9 billion

Growth Rate

CAGR of 6.5% from 2021 to 2028

Base year for estimation

2020

Historical data

2016 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million and CAGR from 2021 to 2028

Report coverage

Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Instrument, procedure type, end-use, region

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; France; Germany; Italy; Spain; U.K.; Belgium; Netherlands; Switzerland; Japan; China; India; Brazil; Mexico; South Africa

Key companies profiled

OvaScience; EMD Serono Inc; Vitrolife AB; Irvine Scientific; Cook Medical Inc.; Cooper Surgical Inc.; Genea Biomedx; Thermo Fisher Scientific Inc.; Progyny, Inc.; Boston IVF

Customization scope

Free report customization (equivalent up to 8 analyst’s working days) with purchase. Addition or alteration to country, regional and segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research has segmented the global in-vitro fertilization market report on the basis of the instrument, procedure type, end-use, and region:

  • Instrument Outlook (Revenue, USD Million, 2016 - 2028)

    • Disposable Devices

    • Culture Media

    • Capital Equipment

  • Procedure Type Outlook (Revenue, USD Million, 2016 - 2028)

    • Fresh Donor

    • Frozen Donor

    • Fresh Non-donor

    • Frozen Non-donor

  • End-use Outlook (Revenue, USD Million, 2016 - 2028)

    • Fertility Clinics

    • Hospitals & Others Setting

  • Regional Outlook (Revenue, USD Million, 2016 - 2028)

    • North America

      • U.S.

      • Canada

    • Europe

      • France

      • Germany

      • Italy

      • Spain

      • U.K.

      • Belgium

      • Netherlands

      • Switzerland

    • Asia Pacific

      • Japan

      • China

      • India

    • Latin America

      • Brazil

      • Mexico

    • Middle East & Africa (MEA)

      • South Africa

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities